For immediate release
The national ‘Talk To Us About Laminitis’ initiative is back for a third year
Although grass can trigger laminitis, up to 90%1, 2 of cases are caused by an underlying hormonal condition, either Cushing’s disease (PPID) or Equine Metabolic Syndrome (EMS).
Moreover, analysis of Cushing’s test results from over 15,000 UK horses and ponies3 has identified that Cushing’s is not just a disease of veteran animals, but could be responsible for laminitis in any horse or pony over the age of 10. In fact, more than a third of the 10-15 year olds within this group were positive for Cushing’s. They were tested because they were showing signs of the disease such as laminitis, abnormal hair coat, muscle wastage and fat deposits round the eyes.Horses or ponies with any of these clinical signs should be tested for Cushing’s so that the condition can be treated and managed appropriately.
With this in mind, the national disease awareness initiative ‘Talk About Laminitis’ will run until the end of October with free laboratory fees available for the blood test used to detect Cushing’s disease. The initiative is aimed at raising awareness of the underlying hormonal causes of laminitis, and is supported by Redwings, The British Horse Society and World Horse Welfare.
To participate in the free testing scheme or for further information talk to your vet or visit www.talkaboutlaminitis.co.uk to download your free blood test voucher*. Early diagnosis and intervention are critical to help reduce the risk of further recurrent episodes of laminitis.
* Free laboratory fees
- Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111–117
- Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123–1127.
- Data from ‘Talk About Laminitis’ 2011-2013. Over 15,000 horses. Boehringer Ingelheim Vetmedica
The ‘Talk About Laminitis’ disease awareness initiative is a campaign supported by Boehringer Ingelheim Limited, Vetmedica Division. Produced by the makers of Prascend. Further information available from Boehringer Ingelheim Limited, Vetmedica Division, Bracknell, Berkshire, RG12 8YS, UK. Date of preparation: April 2014. AHD 8120. Use Medicines Responsibly (www.noah.co.uk/responsible)
For further press information, please contact:
Jessica Henman at MG Communications on 01488 683862 or
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 140 affiliates and more than 46,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine.
Social responsibility is a central element of Boehringer Ingelheim’s culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavours.
In 2012, Boehringer Ingelheim achieved net sales of about 14.7 billion euro of which 22.5% of the net sales from our Prescription Medicine business is invested into research and development.
Further information available from Boehringer Ingelheim Limited, Vetmedica Division.
Talk to your Vet, call your local branch at Milbourn Equine…